Next Article in Journal
Assessment of Macro-Level Socioeconomic Factors That Impact Waterborne Diseases: The Case of Jordan
Next Article in Special Issue
On-Line Monitoring the Growth of E. coli or HeLa Cells Using an Annular Microelectrode Piezoelectric Biosensor
Previous Article in Journal
Health Effects Due to Radionuclides Content of Solid Minerals within Port of Richards Bay, South Africa
Previous Article in Special Issue
Antiviral Activity of Graphene–Silver Nanocomposites against Non-Enveloped and Enveloped Viruses
Article Menu

Export Article

Open AccessReview
Int. J. Environ. Res. Public Health 2016, 13(12), 1182; doi:10.3390/ijerph13121182

Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic Agents

1
School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China
2
Hunan Key Laboratory of Food Safety Science & Technology, Technology Center of Hunan Entry-Exit Inspection and Quarantine Bureau, Hunan Academy of Inspection and Quarantine, Changsha 410004, China
3
State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, China
*
Authors to whom correspondence should be addressed.
Academic Editor: Huang-Tsung Chang
Received: 25 September 2016 / Revised: 21 November 2016 / Accepted: 22 November 2016 / Published: 25 November 2016
View Full-Text   |   Download PDF [3459 KB, uploaded 25 November 2016]   |  

Abstract

Inorganic nanoparticles have been widely investigated as therapeutic agents for cancer treatments in biomedical fields due to their unique physical/chemical properties, versatile synthetic strategies, easy surface functionalization and excellent biocompatibility. This review focuses on the discussion of several types of inorganic nanoparticle-based cancer therapeutic agents, including gold nanoparticles, magnetic nanoparticles, upconversion nanoparticles and mesoporous silica nanoparticles. Several cancer therapy techniques are briefly introduced at the beginning. Emphasis is placed on how these inorganic nanoparticles can provide enhanced therapeutic efficacy in cancer treatment through site-specific accumulation, targeted drug delivery and stimulated drug release, with elaborations on several examples to highlight the respective strategies adopted. Finally, a brief summary and future challenges are included. View Full-Text
Keywords: cancer therapeutic agents; gold nanoparticles; magnetic nanoparticles; upconversion nanoparticles; mesoporous silica nanoparticles cancer therapeutic agents; gold nanoparticles; magnetic nanoparticles; upconversion nanoparticles; mesoporous silica nanoparticles
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Wang, F.; Li, C.; Cheng, J.; Yuan, Z. Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic Agents. Int. J. Environ. Res. Public Health 2016, 13, 1182.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top